Viewing Study NCT04784429



Ignite Creation Date: 2024-05-06 @ 3:51 PM
Last Modification Date: 2024-10-26 @ 1:58 PM
Study NCT ID: NCT04784429
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-02-09
First Post: 2021-03-02

Brief Title: Assessing Outcomes With Microprocessor Knee Utilization in a K2 Population
Sponsor: Otto Bock Healthcare Products GmbH
Organization: Otto Bock Healthcare Products GmbH

Study Overview

Official Title: Assessing Outcomes With Microprocessor Knee Utilization in a K2 Population
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2024-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ASCENT K2
Brief Summary: Two-phased randomized controlled trial comparing the impact of microprocessor controlled knee prostheses MPK with the impact of non-microprocessor controlled knee prostheses NPMK in patients with a transfemoralknee disarticulation level amputation categorized as K2 ambulators
Detailed Description: Randomized controlled trial investigating the benefits of microprocessor controlled knee prostheses MPK in patients with a transfemoral or knee disarticulation level amputation categorized by Medicare Functional Classification Level MFCL as a Limited Community Ambulator K-Level 2 There are two aims for the study Aim 1 is to understand the effect of MPK technology for the K2 ambulator on reducing fear and anxiety of falling improving health-related quality of life and participation in society and activities Aim 2 is to understand the long-term effect of MPK technology the aspects from Aim 1 as well as reducing morbidity The trial will be conducted in two phases Phase 1 will cover the initial 12-month period to address Aim 1 and phase 2 will monitor from 12 months to 5 years to address Aim 2

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None